Search research articles
Contact Us
Filters
Showing results (91-100 of 206) with videos related to
Page
of 21
Sort By:
British Journal of Clinical Pharmacology
|
April 18, 2009
CYP2B6 (c.516G-->T) and CYP2A6 (*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients
Awewura Kwara, Margaret Lartey, Kwamena W Sagoe, et al.
The Journal of Nutritional Biochemistry
|
May 19, 2009
The kinetic basis for age-associated changes in quercetin and genistein glucuronidation by rat liver microsomes
Bradley W Bolling, Michael H Court, Jeffrey B Blumberg, et al.
Journal of Clinical Pharmacology
|
April 28, 2006
Ritonavir has minimal impact on the pharmacokinetic disposition of a single dose of bupropion administered to human volunteers
Leah M Hesse, David J Greenblatt, Lisa L von Moltke, et al.
Frontiers in Veterinary Science
|
November 24, 2025
Delayed postoperative hemorrhage (DEPOH) in an Irish Wolfhound with the <i>SERPINF2</i> c.605 T/T genotype: case description and variant prevalence across dog breeds
Michael H Court, Melissa Hardy, Keith R Forbes, et al.
The Journal of Pharmacy and Pharmacology
|
July 3, 2004
Phenacetin and chlorzoxazone biotransformation in aging male Fischer 344 rats
Jill S Warrington, Michael H Court, David J Greenblatt, et al.
Veterinary Anaesthesia and Analgesia
|
April 25, 2007
Nonsteroidal anti-inflammatory drugs in cats: a review
B Duncan X Lascelles, Michael H Court, Elizabeth M Hardie, et al.
Biopharmaceutics & Drug Disposition
|
April 1, 1997
Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian species
M H Court, L L Von Moltke, R I Shader, et al.
AIDS (London, England)
|
September 26, 2009
CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-dose concentration in HIV-infected patients
Awewura Kwara, Margaret Lartey, Kwamena W C Sagoe, et al.
British Journal of Urology
|
February 1, 1997
Evaluation of primary standard cisplatin-based chemotherapy for clinical stage II non-seminomatous germ cell tumours of the testis
S Culine, C Theodore, B H Court, et al.
Scientific Reports
|
January 11, 2020
Pharmacogenomics of poor drug metabolism in Greyhounds: Cytochrome P450 (CYP) 2B11 genetic variation, breed distribution, and functional characterization
Stephanie E Martinez, Marie C Andresen, Zhaohui Zhu, et al.
Page
of 21
Search research articles
Search
Showing results (91-100 of 206) with videos related to
Sort By:
Page
of 21
British Journal of Clinical Pharmacology
|
April 18, 2009
CYP2B6 (c.516G-->T) and CYP2A6 (*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients
Awewura Kwara, Margaret Lartey, Kwamena W Sagoe, et al.
The Journal of Nutritional Biochemistry
|
May 19, 2009
The kinetic basis for age-associated changes in quercetin and genistein glucuronidation by rat liver microsomes
Bradley W Bolling, Michael H Court, Jeffrey B Blumberg, et al.
Journal of Clinical Pharmacology
|
April 28, 2006
Ritonavir has minimal impact on the pharmacokinetic disposition of a single dose of bupropion administered to human volunteers
Leah M Hesse, David J Greenblatt, Lisa L von Moltke, et al.
Frontiers in Veterinary Science
|
November 24, 2025
Delayed postoperative hemorrhage (DEPOH) in an Irish Wolfhound with the <i>SERPINF2</i> c.605 T/T genotype: case description and variant prevalence across dog breeds
Michael H Court, Melissa Hardy, Keith R Forbes, et al.
The Journal of Pharmacy and Pharmacology
|
July 3, 2004
Phenacetin and chlorzoxazone biotransformation in aging male Fischer 344 rats
Jill S Warrington, Michael H Court, David J Greenblatt, et al.
Veterinary Anaesthesia and Analgesia
|
April 25, 2007
Nonsteroidal anti-inflammatory drugs in cats: a review
B Duncan X Lascelles, Michael H Court, Elizabeth M Hardie, et al.
Biopharmaceutics & Drug Disposition
|
April 1, 1997
Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian species
M H Court, L L Von Moltke, R I Shader, et al.
AIDS (London, England)
|
September 26, 2009
CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-dose concentration in HIV-infected patients
Awewura Kwara, Margaret Lartey, Kwamena W C Sagoe, et al.
British Journal of Urology
|
February 1, 1997
Evaluation of primary standard cisplatin-based chemotherapy for clinical stage II non-seminomatous germ cell tumours of the testis
S Culine, C Theodore, B H Court, et al.
Scientific Reports
|
January 11, 2020
Pharmacogenomics of poor drug metabolism in Greyhounds: Cytochrome P450 (CYP) 2B11 genetic variation, breed distribution, and functional characterization
Stephanie E Martinez, Marie C Andresen, Zhaohui Zhu, et al.
Page
of 21